Traditional Chinese medicine preparation for treating chronic heart failure and preparation method thereof

Abstract

The invention belongs to the field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine preparation for treating chronic heart failure and a preparation method thereof. The traditional Chinese medicine preparation is prepared from following raw materials, by weight, 10-15 parts of panax notoginseng, 15-20 parts of salviae miltiorrhizae, 10-15 parts of prepared rehmannia roots, 3-5 parts of herba cistanche, 3-5 parts of cyperus rotundus, 3-5 parts of cornus officinalis, 1-2 parts of fructus lycii, 2-3 parts of dragon bone, 10-15 parts of apocynum venetum, 3-5 parts of cortex moutan, 5-8 parts of rhizoma chuanxiong, 5-10 parts of herba leonuri and 2-3 parts of rhizoma curculiginis. The traditional Chinese medicines satisfy the specifications in Chinese pharmacopoeia, are safe and reliable, and are combined together to achieve the effects of tonifying and boosting heart qi, activating blood to resolve stasis, promoting dieresis and resolving phlegm. The preparation has definite curative effects on the chronic heart failure, is quick in effects, is high in curative ratio and is free of side effects.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine preparation for treating chronic heart failure and a preparation method thereof. Background technique [0002] Chronic heart failure (CHF) is a clinical syndrome in the severe or terminal stage of various cardiac diseases. The common causes of CHF are coronary heart disease, hypertension, diabetes and various cardiomyopathy, among which heart failure caused by coronary heart disease is the first. [0003] The morbidity and mortality of CHF remain high, which is closely related to the clinical course of CHF. The 2007 Chinese Guidelines for the Diagnosis and Treatment of Chronic Heart Failure and the 2005 American Heart Failure Guidelines both pointed out that CHF is a progressive disease. Once it starts, even if there is no new myocardial damage, it is still in a stable clinical stage and can still continue on its own. devel...

AI Technical Summary

Problems solved by technology

[0008] Traditional drugs for the treatment of CHF mainly include diuretics, ACEI (angiotensin-converting enzyme inhibitors), vasodilators, cardiotonic agents, myocardial nutrients, calcium channel blockers, etc., but they have not fundamentally improved the quality of life of patients , also failed to effectively reduce the mortality rate of CHF, and there are many problems in clinical application